{"id":"https://openalex.org/W16534125","doi":null,"title":"Assessment of the abuse liability of buspirone in recreational sedative users.","display_name":"Assessment of the abuse liability of buspirone in recreational sedative users.","publication_year":1982,"publication_date":"1982-12-01","ids":{"openalex":"https://openalex.org/W16534125","mag":"16534125","pmid":"https://pubmed.ncbi.nlm.nih.gov/6130076"},"language":"en","primary_location":{"id":"pmid:6130076","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6130076","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034220151","display_name":"Jonathan O Cole","orcid":"https://orcid.org/0000-0001-6302-7196","observed_orcids":["https://orcid.org/0000-0001-6302-7196"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J O Cole","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050385199","display_name":"Maressa Hecht Orzack","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M H Orzack","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073293600","display_name":"Barbara Beake","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B Beake","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"M Bird","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Bird","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Y Bar-Tal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y Bar-Tal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.5666,"has_fulltext":false,"cited_by_count":142,"citation_normalized_percentile":{"value":0.80103019,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"43","issue":"12 Pt 2","first_page":"69","last_page":"75"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.5601000189781189,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.5601000189781189,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.3086000084877014,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.08190000057220459,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/buspirone","display_name":"buspirone","score":1.0},{"id":"https://openalex.org/keywords/abuse-potential","display_name":"abuse liability","score":0.9559999704360962},{"id":"https://openalex.org/keywords/methaqualone","display_name":"methaqualone","score":0.9049999713897705},{"id":"https://openalex.org/keywords/diazepam","display_name":"diazepam","score":1.0},{"id":"https://openalex.org/keywords/euphoria","display_name":"euphoria","score":0.8820000290870667},{"id":"https://openalex.org/keywords/sedation","display_name":"sedation","score":0.8370000123977661},{"id":"https://openalex.org/keywords/dysphoria","display_name":"dysphoria","score":0.9929999709129333},{"id":"https://openalex.org/keywords/drug-reinforcement","display_name":"drug reinforcement","score":0.4699999988079071},{"id":"https://openalex.org/keywords/anxiolytics","display_name":"anxiolytics","score":0.6150000095367432},{"id":"https://openalex.org/keywords/addiction-research-center-inventory","display_name":"Addiction Research Center Inventory","score":0.656000018119812}],"concepts":[{"id":"https://openalex.org/C38829236","wikidata":"https://www.wikidata.org/wiki/Q203994","display_name":"Euphoriant","level":2,"score":0.9017844200134277},{"id":"https://openalex.org/C2777287423","wikidata":"https://www.wikidata.org/wiki/Q412194","display_name":"Buspirone","level":4,"score":0.8709337711334229},{"id":"https://openalex.org/C2780421500","wikidata":"https://www.wikidata.org/wiki/Q290620","display_name":"Dysphoria","level":3,"score":0.6251598596572876},{"id":"https://openalex.org/C3018251022","wikidata":"https://www.wikidata.org/wiki/Q3184856","display_name":"Abuse liability","level":3,"score":0.6243121027946472},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6191992163658142},{"id":"https://openalex.org/C2776814716","wikidata":"https://www.wikidata.org/wiki/Q574801","display_name":"Sedation","level":2,"score":0.6161354184150696},{"id":"https://openalex.org/C2776952961","wikidata":"https://www.wikidata.org/wiki/Q423912","display_name":"Methaqualone","level":2,"score":0.6061408519744873},{"id":"https://openalex.org/C2777602617","wikidata":"https://www.wikidata.org/wiki/Q847705","display_name":"Sedative","level":2,"score":0.5584253072738647},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4610947370529175},{"id":"https://openalex.org/C2777196872","wikidata":"https://www.wikidata.org/wiki/Q319877","display_name":"Alprazolam","level":3,"score":0.45016181468963623},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4394929111003876},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.42207491397857666},{"id":"https://openalex.org/C2778195246","wikidata":"https://www.wikidata.org/wiki/Q2622112","display_name":"Physical dependence","level":3,"score":0.41411933302879333},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.41397497057914734},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.32481783628463745},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.13473862409591675},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1113094687461853},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.10843276977539062},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C2777389121","wikidata":"https://www.wikidata.org/wiki/Q81225","display_name":"Morphine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D002065","descriptor_name":"Buspirone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003975","descriptor_name":"Diazepam","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004644","descriptor_name":"Emotions","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005059","descriptor_name":"Euphoria","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006993","descriptor_name":"Hypnotics and Sedatives","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008702","descriptor_name":"Methaqualone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010551","descriptor_name":"Personality","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012054","descriptor_name":"Reinforcement, Psychology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:6130076","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6130076","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Clinical Trial"},{"id":"mag:16534125","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6130076","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2025353116","https://openalex.org/W4242599259","https://openalex.org/W4321060616","https://openalex.org/W2073906775","https://openalex.org/W2048098953","https://openalex.org/W2130757029","https://openalex.org/W2315535731","https://openalex.org/W2526996499","https://openalex.org/W2092582868","https://openalex.org/W3198121616"],"abstract_inverted_index":{"The":[0],"abuse":[1,57,90,111],"potential":[2],"of":[3,65],"buspirone,":[4],"a":[5],"new":[6],"dopaminergic":[7],"antianxiety":[8],"drug,":[9],"was":[10,133],"evaluated":[11],"by":[12],"assessing":[13],"its":[14],"subjective":[15],"effects":[16],"in":[17,41,70,73],"standard":[18],"(10":[19],"mg)":[20,24],"and":[21,36,39,56,89,106,109],"high":[22],"(40":[23],"doses.":[25],"These":[26],"were":[27,59],"compared":[28,93,150],"with":[29],"methaqualone":[30,81],"(300":[31],"mg),":[32,38],"diazepam":[33],"(20":[34],"mg":[35,98,118,131,140,145],"10":[37,130,139],"placebo":[40,137],"24":[42],"casual":[43],"recreational":[44,125],"sedative":[45],"users.":[46],"Addiction":[47],"Research":[48],"Center":[49],"Inventory":[50],"scales":[51,92],"measuring":[52],"euphoria,":[53,86],"sedation,":[54,88,103],"dysphoria,":[55,108],"liability":[58,91,112],"used":[60],"as":[61],"dependent":[62],"measures.":[63],"Groups":[64],"subjects":[66],"received":[67],"all":[68],"treatments":[69],"randomized":[71],"order":[72],"six":[74],"weekly":[75],"4-hour":[76],"sessions.":[77],"Compared":[78],"to":[79,94,121,124,151],"placebo,":[80,95],"caused":[82,100],"elevated":[83],"scores":[84],"on":[85],"physical":[87,102,105],"while":[96],"40":[97,117],"buspirone":[99,115],"increased":[101,104],"mental":[107],"lower":[110],"scores.":[113],"Overall,":[114],"at":[116,143],"appeared":[119],"unlikely":[120],"be":[122],"reinforcing":[123],"illicit":[126],"drug":[127],"users;":[128],"the":[129],"dose":[132],"not":[134],"discriminable":[135],"from":[136],"or":[138],"diazepam.":[141],"Diazepam":[142],"20":[144],"showed":[146],"some":[147],"euphoriant":[148],"effect":[149],"placebo.":[152]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}